Hepatitis
WHO/Yoshi Shimizu
© Credits
Hepatitis

Hepatitis in the South-East Asia Region

Viral hepatitis is the seventh leading cause of mortality worldwide and is the only communicable disease where mortality is increasing. Viral hepatitis cause at least as many, if not more, deaths annually than TB, AIDS or malaria combined.
The word Hepatitis means inflammation (swelling) of the liver. The inflammation can be self-limiting or can progress to fibrosis (scarring), cirrhosis or liver cancer over a period of time . Hepatitis viruses are the most common cause of hepatitis but some other infections, toxic substances (e.g. alcohol, certain drugs), and autoimmune diseases can also cause hepatitis. 

There are five main hepatitis viruses, types A, B, C, D and E. These 5 viruses cause significant burden of illness and death. While hepatitis A and B usually cause outbreaks, B and C infections lead to chronic liver disease and its complications like cirrhosis and liver cancer. WHO estimates that globally there are an estimated 257 million persons with hepatitis B and every year 900 000 people succumb to hepatitis B-related deaths. An estimated 71 million people are infected with hepatitis C globally, an infection that kills over 400 000 people each year.

-

81%

Deaths due to viral hepatitis in SEAR, are attributed to chronic complications of hepatitis B and C

410 000

People die due to viral hepatitis each year in the South-East Asia Region of WHO

10 million

Estimated number of people with hepatitis C in South-East Asia Region of WHO

39 million

Estimated number of people with chronic hepatitis B in South-East Asia Region

On the occasion of World Hepatitis day, Regional Director of WHO South-East Asia region launched a set of 17 training modules on hepatitis B and C screening, diagnosis and treatment. 
The modules were developed by experts and collaborating centers from the WHO South-East Asia and Western Pacific regions, and then field tested through two partner-supported workshops.  
 
These modules are designed to strengthen the capacity of health care providers at all levels, including at the periphery, to provide quality services for hepatitis diagnosis and treatment, which is essential to finding the missing millions and ensuring all people with hepatitis can avoid unnecessary morbidity and mortality. 
 
These modules are now available at the link below and will also be available on WHO WPRO website to promote maximum access and uptake. Where appropriate, the modules should be adapted to the local context and supplemented with local evidence-based practices. All Member States and partners are encouraged to leverage the modules as part of Region-wide efforts to scale up diagnosis and treatment within a universal care package.

Events